Court rules surtax not deductible in income calculation. Physicians' samples cost falls under advertisement expenditure. The court ruled that the liability to pay surtax is not an admissible deduction in computing total income. Regarding the expenditure on physicians' ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Court rules surtax not deductible in income calculation. Physicians' samples cost falls under advertisement expenditure.
The court ruled that the liability to pay surtax is not an admissible deduction in computing total income. Regarding the expenditure on physicians' samples, the Appellate Tribunal held that the cost of free samples supplied to physicians falls within advertisement expenditure under section 37(3A) of the Income-tax Act, 1961. The court emphasized that terms like advertisement, publicity, and sales promotion should be broadly interpreted in the context of the product being promoted. The court ultimately sided with the Revenue, concluding that the expenditure on physicians' samples should be considered as falling within advertisement expenditure.
Issues Involved: The liability to pay surtax as a deduction in computing total income. Whether expenditure on physicians' samples falls within advertisement expenditure under section 37(3A) of the Income-tax Act, 1961.
Liability to Pay Surtax: The court ruled that the liability to pay surtax is not an admissible deduction in computing total income, aligning with a previous decision in CIT v. International Instruments (P.) Ltd. [1983] 144 ITR 936.
Expenditure on Physicians' Samples: The case involved whether the expenditure on physicians' samples should be considered as falling within advertisement expenditure under section 37(3A) of the Income-tax Act, 1961. The Appellate Tribunal held that the cost of free samples supplied to physicians was indeed for sales promotion, as the samples were used to publicize the drugs manufactured by the assessee.
The assessee argued that the samples were provided to gather feedback from medical practitioners and the public to improve the quality of the drugs, not for advertisement or sales promotion. The court considered the interpretation of "advertisement, publicity, and sales promotion," emphasizing that these terms should not be narrowly defined to only include media propaganda but should be understood in the context of the product being promoted.
The court highlighted that for drugs, creating confidence among medical practitioners is crucial, and free samples play a role in confirming the drug's reputation before wider circulation. The timing of providing free samples was also discussed, noting that the continuous supply of samples indicated a promotional aspect rather than mere research and development.
Additionally, the Revenue pointed out that the assessee initially categorized the expenditure under "Advertisement publicity and sales promotion" in the income return, supporting the view that the samples were indeed for promotional purposes. The court concluded that the three terms - advertisement, publicity, and sales promotion - can overlap in certain aspects and should not be narrowly interpreted, ultimately ruling in favor of the Revenue.
Therefore, the court answered the second question in the affirmative, determining that the expenditure on physicians' samples should be considered as falling within advertisement expenditure under section 37(3A) of the Income-tax Act, 1961.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.